Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The Department of Justice prosecuted Tailor Made Compounding LLC, which pleaded guilty to distributing BPC-157 and other unapproved drugs, resulting in forfeiture of $1.79 million
Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
a diet low in fiber can slow down digestion and lead to harder stools that are difficult to pass
Injection burden 1-2 injections per day on overlap days Best for Metabolic + mitochondrial pairing Cycle driver Retatrutide titration sets the pace Retatrutide Loading 1 2 4 6 9 mg (every 4 weeks) Frequency Once weekly Maintenance 9 mg or 12 mg weekly Route SubQ MOTS-c (intermittent - most common) Loading Start Week 5: 5 mg, 2x weekly Frequency 2-3x weekly Maintenance 5-10 mg, 2-3x weekly Route SubQ MOTS-c (low-dose daily - alternative) Loading Start Week 5: 200 mcg/day, +200 mcg every 2 weeks Frequency Daily Maintenance Up to 1 mg daily Route SubQ Weekly Schedule Example - Intermittent MOTS-c (Weeks 5-16) Monday Retatrutide 2 mg (morning) + MOTS-c 5 mg (pre-training) Tuesday Rest day Wednesday MOTS-c 5 mg (pre-training) Thursday Rest day Friday MOTS-c 5 mg (pre-training) Saturday Rest day Sunday Rest day Community protocols use different injection sites and separate syringes when both compounds are dosed the same day
Scientists initially studied BPC-157 for gastrointestinal health
Hepatic-Adjusted Standard BPC-157 dosing in patients with normal liver function typically ranges from 200 to 500 mcg per day, administered subcutaneously or intramuscularly, in cycles of 4 to 8 weeks [1]
US$ 28.43
US$ 29.86
US$ 20.54
US$ 28.92
US$ 28.99
